1993年毕业于上海医科大学药学院，2003年3月毕业于日本国立九州大学药学院制剂设计学专业，获博士学位，2010年任复旦大学教授、博士研究生导师，2011年任复旦大学药剂学教研室主任、教育部智能化递药重点实验室副主任。主要从事药剂学教学工作，主要研究方向为纳米药物靶向递释系统、生物大分子药物载体及给药系统、药物新剂型的研究开发。副主编出版脑靶向递药系统；主持国家863项目、自然科学基金等国家及省部级研究课题9项，授权专利2项，发表论文30篇。2009年获得了首届中国药学会--石药集团青年药剂学奖；2010年入选教育部新世纪人才计划；获得2010年度教育部高等学校科学研究优秀成果奖（科学技术）自然科学一等奖和2010年度上海市自然科学二等奖；获得2010-2011年度第七届“上海市巾帼创新奖”，并荣获“上海市三八红旗手标兵”称号。

Eric Fillion received his BSc degree in biochemistry from the Université de Sherbrooke. After completing his MSc degree in medicinal chemistry at the Université de Montréal with Prof. Denis Gravel, he pursued his doctoral studies at the University of Toronto under the direction of Prof. Mark Lautens. From 1998-2000, he was an NSERC post-doctoral fellow in the laboratories of Prof. Larry E. Overman at the University of California, Irvine. In 2000, he joined the Department of Chemistry at the University of Waterloo, where he is currently a Professor of Chemistry. Since starting his independent career, Fillion has received the Early Research Award from the Government of Ontario, the Astra Zeneca Award in Chemistry, the Boehringer Ingelheim Young Investigator Award for Organic Chemistry, the Research Corporation Research Innovation Award, and the 2011 Canadian Society for Chemistry Merck Frosst Centre for Therapeutic Research Award. The Fillion group has developed a number of transition metal- and Lewis acid-catalyzed carbon-carbon bond forming methods; including enantioselective conjugate alkylation, alkenylation, and alkynylation reactions, as well as intramolecular Friedel-Crafts acylation and alkylation reactions. The synthesis of structurally diverse carbocycles and heterocycles using Lewis acid-catalyzed domino reactions of highly electrophilic alkylidenes was also reported by his laboratories. Most recently, his group has explored the stereoselective modification and functionalization of sp3-hybridized carbon centers by cleavage of unstrained carbon-carbon bonds, and the B(C6F5)3-promoted conjugate addition of alkyl-tricarbastannatranes.

Tomislav Rovis was born in Zagreb, Croatia but raised in Canada. He received his Ph.D. degree with Professor Mark Lautens at the University of Toronto. He was then an NSERC postdoctoral fellow with Professor David A. Evans at Harvard University. In 2000, he began his independent career at Colorado State University. He was promoted to Associate Professor in 2005 and Professor of John K. Stille Chair in 2008. He joined Columbia University in Jul. 2016. His group's accomplishments have been recognized by a number of awards including a GSK Scholar, Amgen Young Investigator, Lilly Granteeship, Montfort Professorship, Roche Excellence in Chemistry, Fellow of the American Association for the Advancement of Science, Katritzky Young Investigator Award of the International Society for Heterocyclic Chemistry and an Arthur C. Cope Scholar.